MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date

Tuesday, September 24, 2019

1:45pm-3:15pm
Does automated analysis of repeat DaTscan imaging aid diagnosis in suspected Lewy body disorders?

F. Richardson, N. Vennart, P. Bartholomew, C. Mcdonald (Gateshead, United Kingdom)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Does lesion localisation predict tremor characteristics in patients with focal cerebellar lesion?

A. Kovács, M. Kiss, A. Kamondi (Budapest, Hungary)

Tremor  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Does the truth lie within the gut? Investigating the gut microbiome in an Australian cohort of Parkinson’s disease patients

J. Kenna, S. Mcgregor, M. Horne, A. Tay, S. Ghosh, F. Mastaglia, A. Jefferson, A. Gorecki, M. Bakeberg, S. Walters, R. Anderton (Perth, Australia)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Does Transcranial Direct Current Simulation Improve Motor Functions in Patients with Parkinson’s disease?

E. Bahbah, M. Morsi, M. Aziz, A. Hassanen, A. Ali, M. Abdelmongy, M. Sinokrot, A. Negida, A. Shalash (Damietta, Egypt)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Domain-specific impact of mood/anxiety disorders on quality of life in idiopathic dystonia

D. Martino, Y. Jasaui, J. Sarna, S. Furtado, S. Patten, T. Pringsheim (Calgary, AB, Canada)

Dystonia  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Drooling in Parkinson’s Disease: A [123I]FP-CIT SPECT study

V. Suarez Contreras, Y. Tayyabah, S. Caminiti, M. Politis (London, United Kingdom)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Drug Utilization in a Real World Cohort with Progressive Supranuclear Palsy

G. Hoeglinger, D. Oleske, J. Zamudio, R. Diegidio, J. Holman (Munich, Germany)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Drug-induced dystonia

JB. Paredes, V. Hristova, J. Poles, S. Madrona, P. Torre, I. Moreno, S. Argos, A. Canovas, JC. Castrillo, JL. Moreno (Madrid, Spain)

Dystonia  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Dry eye in Parkinson’s disease: symptoms, consequences and treatment options

I. Csoti, N. Koleva-Alazeh (Leun, Germany)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Dynamic causal modelling of cortical activity in task-specific dystonia

JC. Chen, CC. Chen (Taichung, Taiwan)

Dystonia  ·  Les Muses Terrace, Level 3
  • «Previous Page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • …
  • 69
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #22901 (not found)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley